We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBD icon
601
Banco Bradesco
BBD
$37.9B
$218K 0.02%
48,381
-18,124
-27% -$85K
AYI icon
602
Acuity Brands
AYI
$10.4B
$215K 0.02%
+933
New +$226K
CDNS icon
603
Cadence Design Systems
CDNS
$93.8B
$215K 0.02%
8,543
-2,182
-20% -$56.1K
RACE icon
604
Ferrari
RACE
$70.8B
$215K 0.02%
3,690
+1,938
+111% +$106K
EWN icon
605
iShares MSCI Netherlands ETF
EWN
$635M
$213K 0.02%
+8,840
New +$213K
OTEX icon
606
Open Text
OTEX
$6.41B
$213K 0.02%
6,884
+684
+11% +$21.3K
SITC icon
607
SITE Centers
SITC
$166M
$213K 0.02%
10,813
+7,324
+210% +$146K
CHS
608
DELISTED
Chicos FAS, Inc.
CHS
$212K 0.02%
14,725
+10,219
+227% +$141K
OLN icon
609
Olin
OLN
$2.17B
$211K 0.02%
8,224
-6,920
-46% -$164K
PNW icon
610
Pinnacle West Capital
PNW
$12.3B
$210K 0.02%
2,682
-716
-21% -$53.7K
PHM icon
611
Pultegroup
PHM
$25.1B
$209K 0.02%
11,390
+9,640
+551% +$183K
CNA icon
612
CNA Financial
CNA
$14.3B
$208K 0.02%
5,016
+3,386
+208% +$129K
EXAS
613
DELISTED
Exact Sciences
EXAS
$208K 0.02%
15,553
+15,236
+4,806% +$246K
CST
614
DELISTED
CST Brands, Inc.
CST
$208K 0.02%
4,311
+1,675
+64% +$80.6K
ARW icon
615
Arrow Electronics
ARW
$11.6B
$207K 0.02%
2,901
-2,667
-48% -$176K
ISBC
616
DELISTED
Investors Bancorp, Inc.
ISBC
$206K 0.02%
+14,774
New +$193K
VAR
617
DELISTED
Varian Medical Systems, Inc.
VAR
$206K 0.02%
+2,623
New +$212K
IDTI
618
DELISTED
Integrated Device Technology I
IDTI
$206K 0.02%
8,727
+5,182
+146% +$120K
BVN icon
619
Compañía de Minas Buenaventura
BVN
$8.19B
$205K 0.02%
18,238
-366
-2% -$4.37K
PBYI icon
620
Puma Biotechnology
PBYI
$397M
$204K 0.02%
6,657
+4,230
+174% +$183K
EWA icon
621
iShares MSCI Australia ETF
EWA
$1.44B
$203K 0.02%
10,040
+9,140
+1,016% +$188K
JNS
622
DELISTED
Janus Capital Group Inc
JNS
$202K 0.02%
15,271
+12,450
+441% +$171K
HWM icon
623
Howmet Aerospace
HWM
$115B
$201K 0.02%
+14,131
New +$212K
PPLI
624
People Inc
PPLI
$3.45B
$201K 0.02%
+17,385
New +$204K
EGN
625
DELISTED
Energen
EGN
$201K 0.02%
3,478
+1,839
+112% +$105K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.